Schedule 13G ownership disclosure

Eucrates Biomedical Acquisition Corp.

Security class unavailable · CUSIP: G3141W114

Event date: 2021-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
730,864
Percent of class
5.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000080255-22-002250
Form type
SC 13G
Filer
Eucrates Biomedical Acquisition Corp.
CIK
CIK 1822929
Filed
Feb 14, 2022
Reporting period
Dec 31, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub